These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27425010)

  • 1. Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.
    Tatovic D; Luzio S; Dunseath G; Liu Y; Alhadj Ali M; Peakman M; Dayan CM;
    Diabet Med; 2016 Nov; 33(11):1564-1568. PubMed ID: 27425010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.
    Jones AG; Besser RE; McDonald TJ; Shields BM; Hope SV; Bowman P; Oram RA; Knight BA; Hattersley AT
    Diabet Med; 2011 Sep; 28(9):1034-8. PubMed ID: 21843301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary C-peptide analysis in an intervention study: experience from the DEFEND-2 otelixizumab trial.
    Ambery P; Donaldson J; Parkin J; Austin DJ
    Diabet Med; 2016 Nov; 33(11):1559-1563. PubMed ID: 26871270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.
    Bowman P; McDonald TJ; Shields BM; Knight BA; Hattersley AT
    Diabet Med; 2012 Jan; 29(1):90-3. PubMed ID: 21883437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home urine C-peptide creatinine ratio can be used to monitor islet transplant function.
    Oram RA; Brooks AM; Forbes S; Eckoldt S; Smith RM; Choudhary P; Rosenthal MJ; Johnson P; Rutter MK; Burling KA; McDonald TJ; Shaw JA; Hattersley AT
    Diabetes Care; 2014 Jun; 37(6):1737-40. PubMed ID: 24623023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinsulin to C-Peptide Ratio in the First Year After Diagnosis of Type 1 Diabetes.
    Freese J; Al-Rawi R; Choat H; Martin A; Lunsford A; Tse H; Mick G; McCormick K
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4318-e4326. PubMed ID: 34228132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes.
    Buchanan K; Mehdi AM; Hughes I; Cotterill A; Le Cao KA; Thomas R; Harris M
    Pediatr Diabetes; 2019 Mar; 20(2):166-171. PubMed ID: 30556344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.
    Hope SV; Jones AG; Goodchild E; Shepherd M; Besser RE; Shields B; McDonald T; Knight BA; Hattersley A
    Diabet Med; 2013 Nov; 30(11):1342-8. PubMed ID: 23659458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.
    Besser RE; Ludvigsson J; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
    Diabetes Care; 2011 Mar; 34(3):607-9. PubMed ID: 21285386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary C-peptide creatinine ratio to differentiate type 2 diabetes mellitus from type 1 in pediatric patients.
    Elzahar W; Arafa A; Youssef A; Erfan A; El Amrousy D
    Eur J Pediatr; 2020 Jul; 179(7):1115-1120. PubMed ID: 32052124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes.
    Wang Y; Gao Y; Cai X; Chen L; Zhou L; Ma Y; Gong S; Han X; Ji L
    J Diabetes Res; 2019; 2019():1747684. PubMed ID: 31485449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet.
    Bogun MM; Bundy BN; Goland RS; Greenbaum CJ
    Diabetes Care; 2020 Aug; 43(8):1836-1842. PubMed ID: 32457058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
    Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
    Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.
    McDonald TJ; Perry MH
    Methods Mol Biol; 2016; 1433():93-102. PubMed ID: 27083170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls.
    Steck AK; Larsson HE; Liu X; Veijola R; Toppari J; Hagopian WA; Haller MJ; Ahmed S; Akolkar B; Lernmark Å; Rewers MJ; Krischer JP;
    Pediatr Diabetes; 2017 Dec; 18(8):794-802. PubMed ID: 28127835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes.
    DiMeglio LA; Cheng P; Beck RW; Kollman C; Ruedy KJ; Slover R; Aye T; Weinzimer SA; Bremer AA; Buckingham B;
    Pediatr Diabetes; 2016 Jun; 17(4):237-43. PubMed ID: 25720763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.
    Ludvigsson J; Krisky D; Casas R; Battelino T; Castaño L; Greening J; Kordonouri O; Otonkoski T; Pozzilli P; Robert JJ; Veeze HJ; Palmer J; Samuelsson U; Elding Larsson H; Åman J; Kärdell G; Neiderud Helsingborg J; Lundström G; Albinsson E; Carlsson A; Nordvall M; Fors H; Arvidsson CG; Edvardson S; Hanås R; Larsson K; Rathsman B; Forsgren H; Desaix H; Forsander G; Nilsson NÖ; Åkesson CG; Keskinen P; Veijola R; Talvitie T; Raile K; Kapellen T; Burger W; Neu A; Engelsberger I; Heidtmann B; Bechtold S; Leslie D; Chiarelli F; Cicognani A; Chiumello G; Cerutti F; Zuccotti GV; Gomez Gila A; Rica I; Barrio R; Clemente M; López Garcia MJ; Rodriguez M; Gonzalez I; Lopez JP; Oyarzabal M; Reeser HM; Nuboer R; Stouthart P; Bratina N; Bratanic N; de Kerdanet M; Weill J; Ser N; Barat P; Bertrand AM; Carel JC; Reynaud R; Coutant R; Baron S
    N Engl J Med; 2012 Feb; 366(5):433-42. PubMed ID: 22296077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.
    Snorgaard O; Hartling SG; Binder C
    Diabetologia; 1990 Jan; 33(1):36-42. PubMed ID: 2303172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.
    Kaas A; Andersen ML; Fredheim S; Hougaard P; Buschard K; Petersen JS; de Beaufort C; Robertson KJ; Hansen L; Mortensen HB; Nielsen LB;
    Pediatr Diabetes; 2012 Feb; 13(1):51-8. PubMed ID: 22118630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed-meal tolerance test to assess residual beta-cell secretion: Beyond the area-under-curve of plasma C-peptide concentration.
    Ruan Y; Willemsen RH; Wilinska ME; Tauschmann M; Dunger DB; Hovorka R
    Pediatr Diabetes; 2019 May; 20(3):282-285. PubMed ID: 30652426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.